EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Management of Dysarthria in Amyotrophic Lateral Sclerosis

Elena Pasqualucci, Diletta Angeletti, Pamela Rosso, Elena Fico iD, Federica Zoccali iD, Paola Tirassa, Armando De Virgilio, Marco de Vincentiis, Cinzia Severini iD

Cells · 09.07.2025 · 14 (14) · 1048

DOI: 10.3390/cells14141048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 09.07.2025. Verfasst von Elena Pasqualucci und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sense Organs, Sapienza University of Rome, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Dysarthria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) stands as the leading neurodegenerative disorder affecting the motor system. One of the hallmarks of ALS, especially its bulbar form, is dysarthria, which significantly impairs the quality of life of ALS patients. This review provides a comprehensive overview of the current knowledge on the clinical manifestations, diagnostic differentiation, underlying mechanisms, diagnostic tools, and therapeutic strategies for the treatment of dysarthria in ALS. We update on the most promising digital speech biomarkers of ALS that are critical for early and differential diagnosis. Advances in artificial intelligence and digital speech processing have transformed the analysis of speech patterns, and offer the opportunity to start therapy early to improve vocal function, as speech rate appears to decline significantly before the diagnosis of ALS is confirmed. In addition, we discuss the impact of interventions that can improve vocal function and quality of life for patients, such as compensatory speech techniques, surgical options, improving lung function and respiratory muscle strength, and percutaneous dilated tracheostomy, possibly with adjunctive therapies to treat respiratory insufficiency, and finally assistive devices for alternative communication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisDysarthriaHumansQuality of Life

Stichwörter der Autor:innen

amyotrophic lateral sclerosis (ALS)diagnosisdysarthriaspeech biomarkersspeech therapy

Autor:innen und Institutionen

  • Department of Sense Organs, Sapienza University of Rome, 00161 Rome, Italy.
  • Insitute of Biochemistry and Cell Biology, National Research Council of Italy, 00161 Rome, Italy.

ORCID-Profile: Elena Fico, Federica Zoccali, Cinzia Severini

Zitieren

APA

Pasqualucci, E., Angeletti, D., Rosso, P., Fico, E., Zoccali, F., Tirassa, P., De Virgilio, A., de Vincentiis, M., & Severini, C. (2025). Management of Dysarthria in Amyotrophic Lateral Sclerosis. Cells, 14(14), 1048. https://doi.org/10.3390/cells14141048

Vancouver

Pasqualucci E, Angeletti D, Rosso P, Fico E, Zoccali F, Tirassa P, et al. Management of Dysarthria in Amyotrophic Lateral Sclerosis. Cells. 2025;14(14):1048. doi:10.3390/cells14141048

BibTeX
@article{Pasqualucci2025,
  author = {Pasqualucci, Elena and Angeletti, Diletta and Rosso, Pamela and Fico, Elena and Zoccali, Federica and Tirassa, Paola and De Virgilio, Armando and de Vincentiis, Marco and Severini, Cinzia},
  title = {Management of Dysarthria in Amyotrophic Lateral Sclerosis},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {14},
  pages = {1048},
  doi = {10.3390/cells14141048}
}
Kostenlos starten →